Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (Text with EEA relevance)
Basic information
Dates Date of document:
  • June 13, 2024
Date of publication:
  • --
Date of effect:
  • July 9, 2024
    • Entry into force - Date pub. See Art 3
  • January 10, 2025
    • Application - Partial application See Art 3
Modified by
Modifies
Modifies:
Affected by case
Legal basis
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE XIV - PUBLIC HEALTH Article 168 (ex Article 152 TEC)
  • Consolidated version of the Treaty on the Functioning of the European Union PART THREE - UNION POLICIES AND INTERNAL ACTIONS TITLE VII - COMMON RULES ON COMPETITION, TAXATION AND APPROXIMATION OF LAWS CHAPTER 3 - APPROXIMATION OF LAWS Article 114 (ex Article 95 TEC)
EuroVoc Vocabulary
  • Market approval
  • EC conformity marking
  • Information system
  • Public health
  • Single market
  • Medical devices
  • Public health
  • Security of supply
  • Internal market - Principles
  • Protection of health and safety
  • Exchange of information
  • Medical device
  • Medical diagnosis
  • Technical barriers